Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 14 January 2003
Vol. 2003, Issue 165, p. tw23
[DOI: 10.1126/stke.2003.165.tw23]

EDITORS' CHOICE

Apoptosis A Small Activator of Apoptosis

The mitochondrial caspase activation pathway regulates caspase-9, a protease that is required for programmed cell death. Various apoptotic stimuli can release cytochrome c from mitochondria and activate caspase-9 through the formation of a proapoptotic protein complex called the apoptosome. Jiang et al. (see the Perspective by Nicholson and Thornberry) discovered a proapoptotic compound through a high throughput chemical screen and then, using a combination of biochemical fractionation and biological tests, identified the molecules responsible for the drug's effect. An oncoprotein called prothymosin-α and a tumor suppressor protein called PHAP (for putative HLA-DR-associated proteins) inhibited or accelerated the apoptosome-caspase-9 pathway, respectively. The study points to the apoptosome as a potential target for drug development.

X. Jiang, H.-E. Kim, H. Shu, Y. Zhao, H. Zhang, J. Kofron, J. Donnelly, D. Burns, S. Ng, S. Rosenberg, X. Wang, Distinctive roles of PHAP proteins and prothymosin-α in a death regulatory pathway. Science 299, 223-226 (2003). [Abstract] [Full Text]

D. W. Nicholson, N. A. Thornberry, Life and death decisions. Science 299, 214-215 (2003). [Summary] [Full Text]

Citation: A Small Activator of Apoptosis. Sci. STKE 2003, tw23 (2003).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882